Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CYP3A subfamily activity affects the equilibrium concentration of Phenazepam® in patients with anxiety disorders and comorbid alcohol use disorder.
Zastrozhin MS, Skryabin VY, Sorokin AS, Petukhov AE, Smirnov VV, Pankratenko EP, Grishina EA, Ryzhikova KA, Panov AS, Savchenko LM, Bryun EA, Sychev DA. Zastrozhin MS, et al. Among authors: smirnov vv. Pharmacogenomics. 2020 May;21(7):449-457. doi: 10.2217/pgs-2019-0071. Epub 2020 Apr 27. Pharmacogenomics. 2020. PMID: 32336193
Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration.
Sychev DA, Zastrozhin MS, Miroshnichenko II, Baymeeva NV, Smirnov VV, Grishina EA, Ryzhikova KA, Mirzaev KB, Markov DD, Skryabin VY, Snalina NE, Nosikova PG, Savchenko LM, Bryun EA. Sychev DA, et al. Among authors: smirnov vv. Drug Metab Pers Ther. 2017 Sep 26;32(3):129-136. doi: 10.1515/dmpt-2017-0021. Drug Metab Pers Ther. 2017. PMID: 28787271
MicroRNAs as Novel Biomarkers for P2Y12 - Inhibitors Resistance Prediction.
Rytkin E, Mirzaev K, Bure I, Akmalova K, Abdullaev S, Kachanova A, Smirnov V, Grishina E, Lyakhova N, Aleshkovich E, Saribekian A, Andreev D, Shabunin A, Sychev D. Rytkin E, et al. Pharmgenomics Pers Med. 2021 Dec 2;14:1575-1582. doi: 10.2147/PGPM.S324612. eCollection 2021. Pharmgenomics Pers Med. 2021. PMID: 34880651 Free PMC article.
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
Rytkin E, Bure IV, Bochkov PO, Akmalova KA, Mirzaev KB, Cherniaeva MS, Ostroumova OD, Smirnov VV, Grishina EA, Saribekian AG, Sychev IN, Sychev DA. Rytkin E, et al. Among authors: smirnov vv. Drug Metab Pers Ther. 2021 Aug 13;37(1):41-46. doi: 10.1515/dmpt-2021-0118. Drug Metab Pers Ther. 2021. PMID: 35385896
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
Rytkin E, Bure IV, Bochkov PO, Akmalova KA, Mirzaev KB, Cherniaeva MS, Ostroumova OD, Smirnov VV, Grishina EA, Saribekian AG, Sychev IN, Sychev DA. Rytkin E, et al. Among authors: smirnov vv. Drug Metab Pers Ther. 2021 Aug 13. doi: 10.1515/dmdi-2021-0118. Online ahead of print. Drug Metab Pers Ther. 2021. PMID: 34390638
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis.
Parkhomenko AA, Zastrozhin MS, Skryabin V, Petukhov AE, Pozdniakov SA, Ivanchenko VA, Zaytsev IA, Bure IV, Bochkov PO, Akmalova KA, Smirnov VV, Bryun EA, Sychev DA. Parkhomenko AA, et al. Among authors: smirnov vv. Psychopharmacol Bull. 2023 Dec 4;53(4):8-14. Psychopharmacol Bull. 2023. PMID: 38076668
305 results